Sign up to save your podcasts
Or
Share MariMed's Vision for Rapid Growth in 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MariMed's Vision for Rapid Growth in 2024
Join us for another TDR Exclusive interview as Shadd Dales, Founder of The Dales Report, sits down with Jon Levine, Chief Executive Officer, Interim CFO & President, MariMed, Inc. In this in-depth conversation, we uncover MariMed's strategic approach to growth, its focus on mergers, acquisitions, financial management, and how it's setting standards in the cannabis industry for 2024.
#Marimedstock #marimedstockanalysis #thedalesreport
Highlights:
🌿 Mergers & Acquisitions: Levine shares insights into MariMed's cautious yet strategic approach to M&A, emphasizing the importance of fit, partnership, and strategic alignment over rapid expansion.
💡 Financial Management: Discussion on how recent loan refinancing impacts MariMed's capital allocation, driving both expansion and operational optimization.
📈 Market Trends & Expansion Plans: Levine outlines MariMed's plans for growth, focusing on states with limited licenses and the potential impact of cannabis rescheduling on the industry and MariMed.
🏢 Operational Excellence: From retail operations to cultivation, MariMed prioritizes quality and consistency. Levine highlights how maintaining high standards in product and operations differentiates MariMed in a competitive market.
🌐 Consumer Trends & Product Strategy: Insights into how MariMed is responding to consumer trends with a significant investment in R&D, aiming to lead with innovation and branded product lines.
📊 Industry Outlook & MariMed's Vision: Levine shares his long-term vision for MariMed within the context of industry trends and challenges, emphasizing sustainable growth, quality, and the importance of patience from investors.
🏆 Community and Brand Loyalty: Highlighting the importance of customer service, loyalty programs, and product variety in retaining and growing MariMed's customer base.
🚀 Looking Ahead: Levine's outlook on the cannabis industry's future and MariMed's strategic position, including anticipation for regulatory changes and their impact on business operations.
View all episodes
By Dales Media Group
5
77 ratings
Join us for another TDR Exclusive interview as Shadd Dales, Founder of The Dales Report, sits down with Jon Levine, Chief Executive Officer, Interim CFO & President, MariMed, Inc. In this in-depth conversation, we uncover MariMed's strategic approach to growth, its focus on mergers, acquisitions, financial management, and how it's setting standards in the cannabis industry for 2024.
#Marimedstock #marimedstockanalysis #thedalesreport
Highlights:
🌿 Mergers & Acquisitions: Levine shares insights into MariMed's cautious yet strategic approach to M&A, emphasizing the importance of fit, partnership, and strategic alignment over rapid expansion.
💡 Financial Management: Discussion on how recent loan refinancing impacts MariMed's capital allocation, driving both expansion and operational optimization.
📈 Market Trends & Expansion Plans: Levine outlines MariMed's plans for growth, focusing on states with limited licenses and the potential impact of cannabis rescheduling on the industry and MariMed.
🏢 Operational Excellence: From retail operations to cultivation, MariMed prioritizes quality and consistency. Levine highlights how maintaining high standards in product and operations differentiates MariMed in a competitive market.
🌐 Consumer Trends & Product Strategy: Insights into how MariMed is responding to consumer trends with a significant investment in R&D, aiming to lead with innovation and branded product lines.
📊 Industry Outlook & MariMed's Vision: Levine shares his long-term vision for MariMed within the context of industry trends and challenges, emphasizing sustainable growth, quality, and the importance of patience from investors.
🏆 Community and Brand Loyalty: Highlighting the importance of customer service, loyalty programs, and product variety in retaining and growing MariMed's customer base.
🚀 Looking Ahead: Levine's outlook on the cannabis industry's future and MariMed's strategic position, including anticipation for regulatory changes and their impact on business operations.
More shows like The Dales Report | Trade to Black
View all
Blunt Business
40 Listeners
Modern Wisdom
3,752 Listeners
Mining Stock Daily
95 Listeners
The Pomp Podcast
1,833 Listeners
The Cannabis Investing Podcast
204 Listeners
Cannabis Investing Network
70 Listeners
The Prof G Pod with Scott Galloway
5,415 Listeners
The Memo by Howard Marks
401 Listeners
The Dime
104 Listeners
Huberman Lab
28,547 Listeners
Honestly with Bari Weiss
8,601 Listeners
On The Tape with Danny Moses
155 Listeners
High Spirits: The Cannabis Business Podcast
6 Listeners
Higher Exchanges
11 Listeners
Prof G Markets
1,164 Listeners